Entelos, Inc. (www.entelos.com) is a
biopharmaceutical company focused on discovering and
developing new therapies for metabolic and inflammatory
disorders. Our mission is to leverage our unique predictive
capability in human biology to dramatically improve how
medicines are discovered, developed, and brought to market.
Using our proprietary PhysioLab biosimulation platforms -
computer-based mathematical models of human disease, we
systematically uncover the biological mechanisms underlying
a disease in order to identify opportunities for therapeutic
intervention and the patients most likely to benefit.
